Drugs / rMenB
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01026974 | Feb → Sep 2010 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT01027351 | Jan → Sep 2010 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00433914 | Feb → Dec 2007 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00381615 | Sep 2006 → Jul 2007 | — | Novartis Vaccines | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01367158 Comparator | Jul 2011 → Jan 2012 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMenB | “BACKGROUND: In a primary study, healthy adolescents received 2 doses (months 0/2) of 1 of the 4 investigational meningococcal ABCWY vaccine formulations, containing components...” PMID 26135245 ↗ Oct 20154“Subjects received either one or two booster doses of the same vaccine they had received in the parent trial (rMenB).” NCT01027351 ↗ |
| Modality | Vaccine | “rMenB vaccine without OMV-NZ” NCT00381615 ↗ |